A Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Hematologic Malignancies

Clinical trial NCT00109707 · COMPLETED

Trial details

NCT number: NCT00109707
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Chronic Myelogenous Leukemia Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)Hypereosinophilic Syndrome Systemic Mastocytosis

Start date: 2005-04-01
Primary completion: 2012-09-01
Enrollment: 507

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.